Focal Segmental Glomerulosclerosis - GCC and Qatar Industry Analysis, Size, Share, Growth, Trends, and Trends and Forecast 2017 - 2024

Jan 2018| TMR124A| Transparency

Report Highlights

Global Focal Segmental Glomerulosclerosis (FSGS) Market: Overview

This report on focal segmental glomerulosclerosis (FSGS) market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacturing and commercialization of diagnostic and therapeutic products for focal segmental glomerulosclerosis (FSGS) as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global focal segmental glomerulosclerosis (FSGS) market with respect to the leading market segments based on disease type, disease management and geographies.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the focal segmental glomerulosclerosis (FSGS) market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global focal segmental glomerulosclerosis (FSGS) market.

Global Focal Segmental Glomerulosclerosis (FSGS) Market: Segmentation

Based on disease type, the focal segmental glomerulosclerosis (FSGS) market has been majorly segmented into primary focal segmental glomerulosclerosis and secondary focal segmental glomerulosclerosis. In terms of disease management, the focal segmental glomerulosclerosis (FSGS) market has been broadly classified into diagnosis and treatment. Diagnosis includes segments such as kidney biopsy, creatine test, and others. Treatment includes segments such as drug therapy, dialysis, and kidney transplant.

Each of the market segments have been extensively analyzed based on the market related factors such as incidence and prevalence of focal segmental glomerulosclerosis (FSGS), available treatments, and pipeline products. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Geographically, focal segmental glomerulosclerosis (FSGS) market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global focal segmental glomerulosclerosis (FSGS) market.

Global Focal Segmental Glomerulosclerosis (FSGS) Market: Competitive Dynamics

The key players operating in the focal segmental glomerulosclerosis (FSGS) market are Variant Pharmaceuticals, Inc., ChemoCentryx, Inc., Retrophin, Inc., AbbVie, Inc., Novartis AG, Pfizer, Inc., AstraZeneca plc., Sanofi S.A, GlaxoSmithKline plc. and Teva Pharmaceutical Industries Ltd. The global focal segmental glomerulosclerosis (FSGS) market is expected to undergo change after the successful pipeline product launch during the forecast period.

The global focal segmental glomerulosclerosis (FSGS) market is segmented as follows:

Global Focal Segmental Glomerulosclerosis (FSGS) Market, by Disease Type

Primary Focal Segmental Glomerulosclerosis
Secondary Focal Segmental Glomerulosclerosis
Global Focal Segmental Glomerulosclerosis (FSGS) Market, by Disease Management

Diagnosis
Kidney Biopsy
Creatine Test
Others
Treatment
Drug Therapy
Dialysis
Kidney Transplant
Global Focal Segmental Glomerulosclerosis (FSGS) Market, by Geography

North America
U.S.
Canada
Europe
Germany
France
Italy
Spain
U.K.
Rest of Europe
Asia Pacific
India
Japan
China
Australia & New Zealand
Rest of Asia
Latin America (LATAM)
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

  • Table 1 : Global Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
  • Table 2 : Global Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management, 2015–2025
  • Table 3 : Global Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management - Diagnosis, 2015–2025
  • Table 4 : Global Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management - Treatment, 2015–2025
  • Table 5 : Global Focal Segmental Glomerulosclerosis Market Revenue (US$ Mn) Forecast, by Region, 2015–2025
  • Table 6 : North America Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 7 : North America Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
  • Table 8 : North America Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management, 2015–2025
  • Table 9 : North America Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease
  • Table 10 : North America Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management - Treatment, 2015–2025
  • Table 11 : Europe Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 12 : Europe Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
  • Table 13 : Europe Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management,
  • Table 14 : Europe Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management - Diagnosis, 2015–2025
  • Table 15 : Europe Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management - Treatment, 2015–2025
  • Table 16 : Asia Pacific Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 17 : Asia Pacific Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
  • Table 18 : Asia Pacific Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management, 2015–2025
  • Table 19 : Asia Pacific Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management - Diagnosis, 2015–2025
  • Table 20 : Asia Pacific Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management - Treatment, 2015–2025
  • Table 21 : Latin America Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 22 : Latin America Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
  • Table 23 : Latin America Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management, 2015–2025
  • Table 24 : Latin America Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management - Diagnosis, 2015–2025
  • Table 25 : Latin America Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management - Treatment, 2015–2025
  • Table 26 : Middle East & Africa Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 27 : Middle East & Africa Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
  • Table 28 : Middle East & Africa Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management, 2015–2025
  • Table 29 : Middle East & Africa Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management - Diagnosis, 2015–2025
  • Table 30 : Middle East & Africa Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, by Disease Management - Treatment, 2015–2025
  • Figure 1 : Market Opportunity Map - By Disease Type, 2016 Revenue Share
  • Figure 2 : Market Opportunity Map - By Disease Management, 2016 Revenue Share
  • Figure 3 : Global Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 4 : Market Value Share, by Disease Management - Diagnosis (2016)
  • Figure 5 : Market Value Share, by Disease Management - Treatment (2016)
  • Figure 6 : Market Value Share, by Disease Type (2016)
  • Figure 7 : Market Value Share, by Region (2016)
  • Figure 8 : Global Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Type, 2016 and 2025
  • Figure 9 : Global Focal Segmental Glomerulosclerosis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Primary Segmental Glomerulosclerosis, 2015–2025z
  • Figure 10 : Global Focal Segmental Glomerulosclerosis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Secondary Focal Segmental Glomerulosclerosis, 2015–2025
  • Figure 11 : Global Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Disease Type, 2015–2025
  • Figure 12 : Global Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management, 2016 and 2025
  • Figure 13 : Global Focal Segmental Glomerulosclerosis Market Value (US$ Mn) and Y-o-Y Growth, by Diagnosis, 2015–2025
  • Figure 14 : Global Focal Segmental Glomerulosclerosis Market Value (US$ Mn) and Y-o-Y Growth, by Treatment, 2015–2025
  • Figure 15 : Global Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Disease Management, 2015–2025
  • Figure 16 : Global Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Region, 2016 and 2025
  • Figure 17 : Global Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Region, 2017–2025
  • Figure 18 : North America Focal Segmental Glomerulosclerosis Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
  • Figure 19 : North America Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Country, 2017–2025
  • Figure 20 : North America Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 21 : North America Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Type, 2016 and 2025
  • Figure 22 : North America Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management, 2016 and 2025
  • Figure 23 : North America Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management - Diagnosis, 2016 and 2025
  • Figure 24 : North America Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management - Treatment, 2016 and 2025
  • Figure 25 : North America Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Disease Type, 2015–2025
  • Figure 26 : North America Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Disease Management, 2015–2025
  • Figure 27 : Europe Focal Segmental Glomerulosclerosis Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
  • Figure 28 : Europe Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
  • Figure 29 : Europe Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 30 : Europe Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Type, 2016 and 2025
  • Figure 31 : Europe Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management, 2016 and 2025
  • Figure 32 : Europe Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management - Diagnosis, 2016 and 2025
  • Figure 33 : Europe Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management - Treatment, 2016 and 2025
  • Figure 34 : Europe Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Disease Type, 2015–2025
  • Figure 35 : Europe Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Disease Management, 2015–2025
  • Figure 36 : Asia Pacific Focal Segmental Glomerulosclerosis Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
  • Figure 37 : Asia Pacific Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
  • Figure 38 : Asia Pacific Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 39 : Asia Pacific Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Type, 2016 and 2025
  • Figure 40 : Asia Pacific Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management, 2016 and 2025
  • Figure 41 : Asia Pacific Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management - Diagnosis, 2016 and 2025
  • Figure 42 : Asia Pacific Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management - Treatment, 2016 and 2025
  • Figure 43 : Asia Pacific Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Disease Type, 2015–2025
  • Figure 44 : Asia Pacific Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Disease Management, 2015–2025
  • Figure 45 : Latin America Focal Segmental Glomerulosclerosis Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
  • Figure 46 : Latin America Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
  • Figure 47 : Latin America Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 48 : Latin America Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Type, 2016 and 2025
  • Figure 49 : Latin America Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management, 2016 and 2025
  • Figure 50 : Latin America Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management - Diagnosis, 2016 and 2025
  • Figure 51 : Latin America Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management - Treatment, 2016 and 2025
  • Figure 52 : Latin America Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Disease Type, 2015–2025
  • Figure 53 : Latin America Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Disease Management, 2015–2025
  • Figure 54 : Middle East & Africa Focal Segmental Glomerulosclerosis Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015-2025
  • Figure 55 : Middle East & Africa Focal Segmental Glomerulosclerosis Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
  • Figure 56 : Middle East & Africa Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 57 : Middle East & Africa Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Type, 2016 and 2025
  • Figure 58 : Middle East & Africa Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management, 2016 and 2025
  • Figure 59 : Middle East & Africa Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management - Diagnosis, 2016-2025
  • Figure 60 : Middle East & Africa Focal Segmental Glomerulosclerosis Market Value Share Analysis, by Disease Management - Treatment, 2016-2025
  • Figure 61 : AbbVie, Inc. - Breakdown of Net Sales, by Region,2015
  • Figure 62 : AbbVie, Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015
  • Figure 63 : Novartis AG Breakdown of Net Sales, by Region, 2016
  • Figure 64 : Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
  • Figure 65 : Pfizer, Inc. Breakdown of Net Sales, by Region, 2015
  • Figure 66 : Pfizer, Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015
  • Figure 67 : AstraZeneca plc Breakdown of Net Sales, by Region, 2015
  • Figure 68 : AstraZeneca plc Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015
  • Figure 69 : Sanofi S.A. Breakdown of Net Sales, by Region, 2015
  • Figure 70 : Sanofi S.A. Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015
  • Figure 71 : GlaxoSmithKline plc. Breakdown of Net Sales, by Region,2015
  • Figure 72 : GlaxoSmithKline plc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015
  • Figure 73 : Teva Pharmaceutical Industries Ltd. Breakdown of Net Sales, by Region, 2015
  • Figure 74 : Teva Pharmaceutical Industries Ltd. Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report